Cargando…

Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2

The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid  may have some minor side effects and in rare cases was accompanied by...

Descripción completa

Detalles Bibliográficos
Autores principales: Savva, Demetris, Battineni, Gopi, Amenta, Francesco, Nittari, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479353/
https://www.ncbi.nlm.nih.gov/pubmed/34597761
http://dx.doi.org/10.1016/j.ijid.2021.09.066
_version_ 1784576236954058752
author Savva, Demetris
Battineni, Gopi
Amenta, Francesco
Nittari, Giulio
author_facet Savva, Demetris
Battineni, Gopi
Amenta, Francesco
Nittari, Giulio
author_sort Savva, Demetris
collection PubMed
description The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid  may have some minor side effects and in rare cases was accompanied by severe or immediate reactions. The development of hyaluronic acid soft tissue filler delayed inflammatory reactions following COVID-19 vaccination was reported.  Treatments based on hyaluronic acid represent one of the most largely used practice of aesthetic medicine. In this we present a case of a 38-year-old female patient with a confirmed hypersensitivity reaction after having the BNT162b2 vaccine (Pfizer, USA). This case indicates that an adequate patient knowledge prior to hyaluronic acid injections to avoid adverse effect of a delayed-type hypersensitivity response after COVID-19 vaccination is desirable.
format Online
Article
Text
id pubmed-8479353
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
record_format MEDLINE/PubMed
spelling pubmed-84793532021-09-29 Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2 Savva, Demetris Battineni, Gopi Amenta, Francesco Nittari, Giulio Int J Infect Dis Article The ongoing vaccination program in the control of novel coronavirus (COVID-19)is providing an opportunity to public health authorities to emerge from the current pandemic crisis.Covid vaccination which protects from getting Covid  may have some minor side effects and in rare cases was accompanied by severe or immediate reactions. The development of hyaluronic acid soft tissue filler delayed inflammatory reactions following COVID-19 vaccination was reported.  Treatments based on hyaluronic acid represent one of the most largely used practice of aesthetic medicine. In this we present a case of a 38-year-old female patient with a confirmed hypersensitivity reaction after having the BNT162b2 vaccine (Pfizer, USA). This case indicates that an adequate patient knowledge prior to hyaluronic acid injections to avoid adverse effect of a delayed-type hypersensitivity response after COVID-19 vaccination is desirable. The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021-12 2021-09-29 /pmc/articles/PMC8479353/ /pubmed/34597761 http://dx.doi.org/10.1016/j.ijid.2021.09.066 Text en © 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Savva, Demetris
Battineni, Gopi
Amenta, Francesco
Nittari, Giulio
Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_full Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_fullStr Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_full_unstemmed Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_short Hypersensitivity reaction to hyaluronic acid dermal filler after the Pfizer vaccination against SARS-CoV-2
title_sort hypersensitivity reaction to hyaluronic acid dermal filler after the pfizer vaccination against sars-cov-2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479353/
https://www.ncbi.nlm.nih.gov/pubmed/34597761
http://dx.doi.org/10.1016/j.ijid.2021.09.066
work_keys_str_mv AT savvademetris hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2
AT battinenigopi hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2
AT amentafrancesco hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2
AT nittarigiulio hypersensitivityreactiontohyaluronicaciddermalfillerafterthepfizervaccinationagainstsarscov2